Perioperative antimicrobial prophylaxis in clean-contaminated head and neck squamous cell cancer surgeries: Is less better?

被引:1
|
作者
Kohli, Pavneet [1 ]
Penumadu, Prasanth [1 ]
Shukkur, Naveeth [1 ]
Sivasanker, M. [3 ]
Balasubramanian, Arumugam [1 ]
Ganapathy, Sachit [2 ]
机构
[1] JIPMER, Dept Surg Oncol, Pondicherry, India
[2] JIPMER, Dept Biostat, Pondicherry, India
[3] Royal Liverpool Univ Hosp NHS Trust, Dept Surg, Liverpool, Merseyside, England
关键词
Antibiotic misuse; antibiotic resistance; clean-contaminated surgery; head and neck surgery; oral cancer; SSI; SURGICAL SITE INFECTIONS; ANTIBIOTIC-PROPHYLAXIS; ONCOLOGIC SURGERY; SHORT-TERM; COMPLICATIONS; PREVENTION; CLASSIFICATION; METRONIDAZOLE; CLINDAMYCIN; CEFAZOLIN;
D O I
10.4103/jcrt.JCRT_1654_20
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Judicious use of antibiotics and stringent adherence to practice guidelines is the need of the hour as antibiotic resistance is a rampant problem. Despite several reports in the literature describing the optimal duration of antibiotics, there is no consensus. A "one for all" protocol may be impractical and hence the guidelines need to be tweaked to take into consideration local factors. We designed a protocol for prophylactic antibiotics in clean-contaminated head and neck cancer squamous cell carcinoma (HNSCC) surgeries to prevent unchecked abuse and evaluated its feasibility. Materials and Methods: Two hundred consecutive patients who underwent a clean-contaminated surgery for HNSCC between January 2017 and December 2019 were included. Single-dose intravenous amoxicillin-clavulanate at induction followed by three doses of amoxicillin-clavulanate, metronidazole, and amikacin in the postoperative period was used. Adherence to the antibiotic protocol was assessed from a prospectively maintained database. Results: The mean age was 55.99 +/- 11.71 years. The protocol was effective in 70% of the patients with an acceptable surgical site infection (SSI) rate of 12%. Flap-related complications (9.5%) and oro-cutaneous fistula (5%) were common causes of prolonged antibiotics. On univariate analysis, blood transfusion (P =.014), clinical stage at presentation (P =.028), patients undergoing reconstruction (P =.001), longer operative time (P =.009), and pathological T stage (P = 0.03) were at higher chance of deviating from the protocol. On multivariate analysis, age more than 50 years (OR: 2.14, 95% CI: (1.01, 4.52); P value = 0.047) and reconstruction (OR: 3.36, 95% CI: (1.21, 9.32); P value = 0.020) were found to be significant. Conclusions: A three-dose perioperative antibiotic prophylaxis in clean-contaminated HNSCC surgeries is feasible. Similar protocols should be developed and validated at other major centers to limit the unnecessary use of antibiotics and prevent the emergence of antibiotic resistance.
引用
收藏
页码:S170 / S176
页数:7
相关论文
共 50 条
  • [21] Oral health and risk for head and neck squamous cell carcinoma: the Carolina Head and Neck Cancer Study
    Kimon Divaris
    Andrew F. Olshan
    Joanna Smith
    Mary E. Bell
    Mark C. Weissler
    William K. Funkhouser
    Patrick T. Bradshaw
    Cancer Causes & Control, 2010, 21 : 567 - 575
  • [22] Patterns of gene promoter methylation in squamous cell cancer of the head and neck
    Masayuki Hasegawa
    Heather H Nelson
    Edward Peters
    Elin Ringstrom
    Marshall Posner
    Karl T Kelsey
    Oncogene, 2002, 21 : 4231 - 4236
  • [23] Multiple primary head and neck squamous cell cancer: Lessons learnt
    Ghogale, Kshitish S.
    Naorem, Raphel
    Waghmare, Chaitali M.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 2) : S658 - S663
  • [24] Patterns of gene promoter methylation in squamous cell cancer of the head and neck
    Hasegawa, M
    Nelson, HH
    Peters, E
    Ringstrom, E
    Posner, M
    Kelsey, KT
    ONCOGENE, 2002, 21 (27) : 4231 - 4236
  • [25] Multiple primary head and neck squamous cell cancer: Lessons learnt
    Ghogale, Kshitish S.
    Naorem, Raphel
    Waghmare, Chaitali M.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 : S658 - S663
  • [26] Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer
    Segna, E.
    Civita, F.
    Denaro, N.
    Beltramini, G. A.
    ORAL ONCOLOGY, 2024, 152
  • [27] Emerging strategies for the early detection and prevention of head and neck squamous cell cancer
    Dasgupta, Santanu
    Dash, Rupesh
    Das, Swadesh K.
    Sarkar, Devanand
    Fisher, Paul B.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (02) : 467 - 473
  • [28] Immunohistochemical Analysis of Common Cancer Antigens in Head and Neck Squamous Cell Carcinoma
    Morishita, Yohei
    Takenouchi, Kazumasa
    Sakashita, Shingo
    Matsuura, Kazuto
    Hayashi, Ryuichi
    Nakatsura, Tetsuya
    ANTICANCER RESEARCH, 2022, 42 (12) : 5751 - 5761
  • [29] Integration of chemotherapy into the definitive management of squamous cell head and neck cancer.
    Adelstein D.J.
    Current Oncology Reports, 1999, 1 (2) : 97 - 98
  • [30] Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas
    Lim, Young Chang
    Oh, Se-Yeong
    Cha, Yun Yi
    Kim, Sung-Hak
    Jin, Xun
    Kim, Hyunggee
    ORAL ONCOLOGY, 2011, 47 (02) : 83 - 91